CHYM vs ABTC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CHYM Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Chime Financial, Inc. Class A Common Stock (CHYM) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ABTC counters with relative strength in Valuation. Fundamentally, CHYM trades at 31.6x Forward P/E with 19.3% operating margin (+32.1% YoY revenue) versus ABTC at 4.9x Forward P/E and -38.7% operating margin (-1.3% YoY). In options structure, CHYM sits in CONSOLIDATION (12th %ile IV; Dealer Gamma Walls on Pro) against ABTC sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CHYM Revenue | ABTC Revenue | CHYM Op. Margin | ABTC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $10M | N/A | -23.5% | ABTC |
| FY2019 | N/A | $10M | N/A | -115.6% | ABTC |
| FY2020 | N/A | $10M | N/A | -137.4% | ABTC |
| FY2021 | N/A | $20M | N/A | -187.8% | ABTC |
| FY2022 | N/A | $10M | N/A | -412.0% | ABTC |
| FY2023 | $1.28B | $60M | -18.4% | 9.6% | ABTC |
| FY2024 | $1.67B | $70M | -3.7% | 676.7% | ABTC |
| FY2025 | $2.19B | $190M | -47.6% | -123.1% | CHYM |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CHYM | ABTC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.9B | $369.2M | Larger Scale | CHYM |
| Trailing P/E Ratio Valuation | 29.4x | 3.5x | Lower Multiple | ABTC |
| Forward P/E Ratio Valuation | 31.6x | 4.9x | Lower Multiple | ABTC |
| Revenue Growth (YoY) Growth | +32.1% | -1.3% | Higher Growth | CHYM |
| Operating Margin (TTM) Profitability | 19.3% | -38.7% | Higher Margin | CHYM |
| Net Profit Margin Profitability | 3.0% | -26.7% | Higher Margin | CHYM |
| Return on Equity (ROE) Capital Efficiency | 5.4% | -10.5% | Higher ROE | CHYM |
| 52-Week Range Position Momentum | 94% ($16โ$36) | 40% ($1โ$11) | Stronger Trend | CHYM |
| Beta / 30D Volatility Risk Regime | 1.44ฮฒ ยท 36% Vol | 11.45ฮฒ ยท 103% Vol | Lower Realized Risk | CHYM |
| Unified Institutional Score Composite Signal | 33.1 / 100 (SELL) | 59.1 / 100 (HOLD) | Higher Composite | ABTC |